Women's Health Drugs Flashcards
Alendronate (Fosamax)
Chemical Classification
Bisphosphate
Alendronate (Fosamax)
Mechanism of Action
Decreases rate of bone resorption and may directly block dissolution of hydroxyapatite crystals of bone, inhibits osteoclast activity
Alendronate (Fosamax)
Uses
Treatment and prevention of osteoporosis in postmenopausal women, treatment of osteoporosis in men, Paget’s disease, treatment of corticosteroid-induced osteoporosis in postmenopausal women in receiving estrogen and in men who are on continuing corticosteroid treatment with low bone mass
Alendronate (Fosamax)
Contraindications
Hypersensitivity to bisphosphonates, delayed esophageal emptying, inability to sit or stand for 30 min, hypocalcemia
Alendronate (Fosamax)
Side Effects
CNS: headache
CV: ATRIAL FIBRILLATION
GI: abdominal pain, constipation, nausea, vomiting, esophageal, ulceration, acid reflux, dyspepsia, ESOPHAGEAL PERFORATION, diarrhea, ESOPHAGEAL CANCER
META: hypophosphatemia, hypocalcemia
MS: bone pain, osteonecrosis of the jaw, bone fractures
SYST: ANGIOEDEMA, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS
Alendronate (Fosamax)
Nursing Considerations
ASSESS:
- Serious reactions: angioedema, Stevens-Johnson syndrome, toxic epidermal necrolysis, atrial fibrillation
- Hormonal status if a woman, before treatment
- FOR OSTEOPOROSIS: bone density test before and during treatment
- FOR PAGET’S DISEASE: increased skull size, bone pain, headache; decreased vision, hearing
- Electrolytes; BUN/creatinine; calcium, phosphorous, magnesium, potassium
- FOR HYPERCALCEMIA: paresthesia, twitching, laryngospasm; Chvostek’s, Trousseau’s signs
- Alk phos levels, baseline and periodically, 2 x upper limit of normal is indicative of Paget’s disease
- Dental status: regular dental exams should be performed; dental extractions (cover with antiinfectives before procedure)
Dinoprostone (Cervidil)
Functional Classification
Oxytocic, abortifacient
Dinoprostone (Cervidil)
Chemical Classification
Prostaglandin E2
Dinoprostone (Cervidil)
Mechanism of Action
Stimulates uterine contractions, causing abortion; acts within 30hr for complete abortion
Dinoprostone (Cervidil)
Uses
Abortion during 2nd trimester, benign hydatidiform mole, expulsion of uterine contents in fetal deaths to 28 wk, missed abortion, to efface and dilate the cervix in pregnancy at term
Dinoprostone (Cervidil)
Contraindications
Hypersensitivity, C-section, surgery
Dinoprostone (Cervidil)
Side Effects
CNS: Headache, dizziness, chills, fever, flushing
CV: hypotension, DYSRHYTHMIAS, DIC
EENT: blurred vision
SYST: ANAPHYLACTOID SYNDROME OF PREGNANCY
FETAL: bradycardia (i.e., deceleration)
GI: Nausea, Vomiting, Diarrhea
GU: vaginitis, vaginal pain, vulvitis, vaginismus
INTEG: rash, skin color changes
MS: Leg Cramps, Joint Swelling, weakness
GEL: uterine contractile abnormality, GI side effects, back pain, fever
INSERT: uterine hyperstimullation, fever, nausea, vomiting, diarrhea, abdominal pain
SUPPOSITORY: UTERINE RUPTURE, ANAPHYLAXIS
Dinoprostone (Cervidil)
Nursing Considerations
ASSESS:
- CERVICAL RIPENING: dilation, effacement of cervix and uterine contraction, fetal heart tones, check for contractions over 1 min
- For fever that occurs 1/2hr after suppository insertion (abortion)
- Respiratory rate, rhythm, depth; notify prescriber of abnormalities, pulse, BP, temp
- VAGINAL DISCHARGE: check for itching, irritation; indicates vaginal infection
Methylergonovine (Methergine)
Functional Classification
Oxytocic
Methylergonovine (Methergine)
Chemical Classification
Ergot alkaloid